CVAC
Price:
$4.66
Market Cap:
$914.43M
CureVac N.V. is a biopharmaceutical company currently in the clinical stage, specializing in creating innovative medical treatments leveraging messenger ribonucleic acid (mRNA) technology. Its portfolio encompasses various mRNA-based prophylactic vaccines. Among these is CV2CoV, an mRNA vaccine candidate addressing SARS-CoV-2, presently in Phase 1 clinical investigation. Another key candidate, CV7202, an mRNA prophylactic targeting the rabies virus glycoprotein, has successfully completed its Phase 1 clinical evaluation. Additionally, CVSQIV, aimed at influenza, is also undergoing Phase 1 clinical trials. Further vaccine development efforts are directed towards lassa fever, yellow fever, res...[Read more]
Industry
Biotechnology
IPO Date
2020-08-14
Stock Exchange
NASDAQ
Ticker
CVAC
According to CureVac N.V.’s latest financial reports and current stock price. The company's current PE Ratio is 6.96. This represents a change of -335.52% compared to the average of -2.95 of the last 4 quarters.
The mean historical PE Ratio of CureVac N.V. over the last ten years is -42.60. The current 6.96 PE Ratio has changed -1732.66% with respect to the historical average. Over the past ten years (40 quarters), CVAC's PE Ratio was at its highest in in the September 2025 quarter at 0.95. The PE Ratio was at its lowest in in the December 2021 quarter at -703.11.
Average
-42.60
Median
-13.63
Minimum
-120.40
Maximum
4.56
Discovering the peaks and valleys of CureVac N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 4.56
Minimum Annual Increase = -241.14%
Minimum Annual PE Ratio = -120.40
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 4.56 | -241.14% |
| 2023 | -3.23 | -24.51% |
| 2022 | -4.28 | -68.63% |
| 2021 | -13.63 | -79.93% |
| 2020 | -67.94 | -27.18% |
| 2019 | -93.29 | -22.52% |
The current PE Ratio of CureVac N.V. (CVAC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.98
5-year avg
-16.90
10-year avg
-42.60
CureVac N.V.’s PE Ratio is greater than Novavax, Inc. (-16.91), greater than Nektar Therapeutics (-7.24), greater than Syndax Pharmaceuticals, Inc. (-6.79), greater than Inhibrx Biosciences, Inc. (-11.09), greater than Amylyx Pharmaceuticals, Inc. (-10.59), greater than Immatics N.V. (-4.98), greater than Relay Therapeutics, Inc. (-10.11), greater than ORIC Pharmaceuticals, Inc. (-5.90), greater than Enliven Therapeutics, Inc. (-27.50), greater than Tourmaline Bio, Inc. (-18.09),
| Company | PE Ratio | Market cap |
|---|---|---|
| -16.91 | $1.50B | |
| -7.24 | $1.19B | |
| -6.79 | $1.68B | |
| -11.09 | $1.37B | |
| -10.59 | $1.30B | |
| -4.98 | $1.31B | |
| -10.11 | $2.78B | |
| -5.90 | $878.86M | |
| -27.50 | $3.15B | |
| -18.09 | $1.23B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CureVac N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CureVac N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CureVac N.V.'s PE Ratio?
How is the PE Ratio calculated for CureVac N.V. (CVAC)?
What is the highest PE Ratio for CureVac N.V. (CVAC)?
What is the 3-year average PE Ratio for CureVac N.V. (CVAC)?
What is the 5-year average PE Ratio for CureVac N.V. (CVAC)?
How does the current PE Ratio for CureVac N.V. (CVAC) compare to its historical average?